Intrabio Inc
Clinical trials sponsored by Intrabio Inc, explained in plain language.
-
Hope for rare brain disease: new drug trial targets movement and daily life
Disease control Recruiting nowThis study tests a drug called N-acetyl-L-leucine (IB1001) in people aged 4 and older with Niemann-Pick disease type C, a rare genetic disorder that affects movement and thinking. The trial compares the drug to a placebo to see if it improves coordination and quality of life. Aft…
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for rare disease: expanded access to experimental drug for A-T patients
Disease control AVAILABLEThis program provides an experimental drug, levacetylleucine, to people with Ataxia-Telangiectasia (A-T), a rare genetic disease that affects movement and immunity. It is for patients who cannot join clinical trials and have no other good treatment options. The goal is to offer p…
Sponsor: IntraBio Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC